Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock (Q35621102)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2004
edit
Language Label Description Also known as
English
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock
scientific article published on January 2004

    Statements

    Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock (English)
    0 references
    0 references
    0 references
    Michael S Silverman

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit